))
Innovation In Science and Medicine: Potential Implications for Health Policy? - The Chancellor’s Health Policy Lecture Series
Archived series ("Inactive feed" status)
When?
This feed was archived on June 24, 2018 16:18 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 189706241 series 1665262
Content provided by UC San Francisco (Video). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Francisco (Video) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. Hal Barron discusses what he has learned about innovation in science and medicine based on his over 20 years of experience in the biotechnology industry, and potential implications for health policy at the local, national and global level. Barron is one of the most respected clinician-scientists and successful drug developers in the biotechnology industry and serves as Calico’s president of research and development. Series: "Philip R. Lee Institute for Health Policy Studies" [Professional Medical Education] [Show ID: 32821]
…
continue reading
201 episodes
Share
